Developer docs
API playgroundTry for free, no card

Search company profiles

Hevolution Foundation

Full company profile

uuid0008xut

Namestring
Hevolution Foundation
Legal namestring
Hevolution Foundation
Websiteurl
hevolution.com
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRiyadh, Saudi Arabia
HQ citystring
Riyadh
HQ countrystring
Saudi Arabia
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research funding, geroscience research grants, healthspan science investments, aging therapeutics funding, longevity biotech grants
Industry2 codes
PRIMARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code3 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services81321
Product category
Philanthropic Research Funding
Revenue model1 record
1Philanthropic grants and early-stage investments
TypeLicensing Royalties
Description

Hevolution Foundation operates as a non-profit organization that provides grants and early-stage investments to incentivize independent research and entrepreneurship in healthspan science. The foundation funds aging biology research, geroscience, and clinical trials, reinvesting all returns into the field rather than extracting profits.

hevolution.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Global Healthspan Summit
Description

A global convening event organized by Hevolution Foundation to advance healthspan science, bringing together scientists, researchers, policymakers, investors, and biotech entrepreneurs.

hevolution.com
Core offering1 text field

Hevolution Foundation is a non-profit organization that provides philanthropic grants and early-stage investments to fund aging biology, geroscience, and healthspan research worldwide. The foundation supports academic researchers, postdoctoral fellows, and early-stage biotech companies developing therapeutics that target the root causes of aging, reinvesting any returns back into the field rather than extracting profits.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reducing period of poor health by just 12 months could generate trillions of dollars annually through higher productivity and lower healthcare costs
+2 more records
Product overview1 text field

Hevolution Foundation is a global non-profit organization (not a product company) that provides philanthropic grants and early-stage investments to advance healthspan science. The foundation's offerings include: research grant programs (such as HF-GRO, HF-AGE, HF-PTG, HF-GLA, and Saudi Arabia-specific programs) supporting scientists working on aging biology and geroscience; investment in early-stage biotech companies developing therapies targeting root causes of aging; the Global Healthspan Summit (an annual convening of scientists, researchers, policymakers, investors, and biotech entrepreneurs); and the Global Healthspan Report (an annual publication presenting evidence on aging as a manageable process). These offerings work together to incentivize independent research, build the geroscience ecosystem, and drive the field from basic biology through clinical translation.

Product and service7 records
1HF-GRO Program
CategoryResearch Grants
2HF-AGE Program
CategoryResearch Grants
3HF-PTG Program
CategoryResearch Grants
4HF-GLA Program
CategoryResearch Grants
5Saudi Arabia Postdoctoral Fellowships
CategoryResearch Grants
6Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
CategoryResearch Grants
7Early-Stage Biotech Investments
CategoryVenture Investments
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Partnership on the $101 million XPRIZE Healthspan competition to drive breakthroughs in healthy aging. Hevolution co-founded this initiative to accelerate the field of geroscience and incentivize global innovation in healthspan extension.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership with Impetus Grants as part of Hevolution's global partnerships to accelerate impact, build capacity, acquire knowledge, and increase awareness in healthspan science.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-development of Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research, providing $375,000 awards over 3 years to junior investigators in Canada and the United States. Also jointly manages the Hevolution Foundation Scientific Conferences Fund.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Investment in Lausanne-based Swiss biotech company Vandria as part of Hevolution's portfolio of companies advancing healthspan science.

5Saudi Arabia National Biotechnology Strategy
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alignment with Saudi Arabia's National Biotechnology Strategy which aims to contribute over $34 billion to non-oil GDP by 2040, positioning the Kingdom as a leader in geroscience research.

vision2030.gov.sa
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Hevolution's HF-AGE program funds projects that were deemed meritorious in NIH peer review but not funded by the National Institute on Aging (NIA) in fiscal year 2023.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

SENS is a nonprofit foundation funding research into the biological drivers of aging and age-related disease. It overlaps directly with Hevolution's mission of advancing geroscience research and serves a similar investigator base.

TypeBroad incumbent
Description

A well-capitalized private biotechnology company focused on cellular rejuvenation programming to treat aging and age-related diseases. Comparable as a deep-pocketed private longevity player, but operating as a commercial entity rather than a grantmaking foundation.

TypeOthers
Description

A nonprofit that runs large incentive competitions to drive breakthrough innovation. Comparable as a prize-based ecosystem builder, and a direct partner through the $101M XPRIZE Healthspan initiative co-founded by Hevolution.

TypeDirect peer
Description

A nonprofit that funds research and projects aimed at extending healthy human longevity, including through grants and prizes. It is a direct peer in the healthspan philanthropy category, with comparable grantmaking and ecosystem-building activity.

5Howard Hughes Medical Institute
TypeBroad incumbent
Description

A large biomedical research philanthropy funding scientists and institutes across the life sciences. Comparable in scale and operating model as a major nonprofit research funder with long investment horizons.

TypeBroad incumbent
Description

A nonprofit program funded by the Wellcome Trust that makes large, milestone-driven grants in human health, including aging-related programs. Comparable as a well-capitalized philanthropic health-research funder with global ambitions.

TypeDirect peer
Description

AFAR is a US-based nonprofit that funds aging biology and geroscience research through grants and investigator awards — the closest functional peer to Hevolution. It is also an active co-development partner on the Hevolution/AFAR New Investigator Awards and the Scientific Conferences Fund.

TypeBroad incumbent
Description

Alphabet-backed R&D company focused on aging biology and age-related diseases. Not a grantmaker, but a deep-pocketed private player in the same healthspan mission, competing for the same scientific talent and discoveries.

9National Institute on Aging (NIA / NIH)
TypeBroad incumbent
Description

The largest public funder of aging research in the US, supporting a broad biomedical research portfolio. Hevolution's HF-AGE program specifically funds projects deemed meritorious in NIA peer review but unfunded — making NIA both a complementary and competing capital source.

TypeEmerging player
Description

An independent nonprofit biomedical research institute dedicated to aging research. It is a partial peer — a research operator and grant recipient in the same field — and a potential partner or grantee for Hevolution programs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment7 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hevolution Foundation

Philanthropic Research Fundinghevolution.com

Hevolution Foundation firmographics

Firmographics
Name
Hevolution Foundation
Legal name
Hevolution Foundation
Website
https://hevolution.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Hevolution Foundation industry classification

Industry
Product category
Philanthropic Research Funding
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)
akta.pro industry
PRIMARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Biomedical research funding
  • Geroscience research grants
  • Healthspan science investments
  • Aging therapeutics funding
  • Longevity biotech grants

Where Hevolution Foundation is headquartered

Location

Headquarters

HQ city
Riyadh
HQ country
Saudi Arabia
HQ region
Middle East

Offices2 records

Markets served

Hevolution Foundation business model

Business model
GTM type
B2B
Offering type
Services

Revenue model

  1. Philanthropic grants and early-stage investments: Hevolution Foundation operates as a non-profit organization that provides grants and early-stage investments to incentivize independent research and entrepreneurship in healthspan science. The foundation funds aging biology research, geroscience, and clinical trials, reinvesting all returns into the field rather than extracting profits.

Distribution channels1 record

Marketing channels6 records

Hevolution Foundation product offering

Product offering

Core offering

Hevolution Foundation is a non-profit organization that provides philanthropic grants and early-stage investments to fund aging biology, geroscience, and healthspan research worldwide. The foundation supports academic researchers, postdoctoral fellows, and early-stage biotech companies developing therapeutics that target the root causes of aging, reinvesting any returns back into the field rather than extracting profits.

Product overview

Hevolution Foundation is a global non-profit organization (not a product company) that provides philanthropic grants and early-stage investments to advance healthspan science. The foundation's offerings include: research grant programs (such as HF-GRO, HF-AGE, HF-PTG, HF-GLA, and Saudi Arabia-specific programs) supporting scientists working on aging biology and geroscience; investment in early-stage biotech companies developing therapies targeting root causes of aging; the Global Healthspan Summit (an annual convening of scientists, researchers, policymakers, investors, and biotech entrepreneurs); and the Global Healthspan Report (an annual publication presenting evidence on aging as a manageable process). These offerings work together to incentivize independent research, build the geroscience ecosystem, and drive the field from basic biology through clinical translation.

Differentiator

Problem solved

Functional benefit

Brands

  • Global Healthspan Summit: A global convening event organized by Hevolution Foundation to advance healthspan science, bringing together scientists, researchers, policymakers, investors, and biotech entrepreneurs.

Products and services

  • HF-GRO Program
  • HF-AGE Program
  • HF-PTG Program
  • HF-GLA Program
  • Saudi Arabia Postdoctoral Fellowships
  • Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
  • Early-Stage Biotech Investments

Quantifiable outcome

  • Reducing period of poor health by just 12 months could generate trillions of dollars annually through higher productivity and lower healthcare costs
  • +2 more outcomes

Companies that use Hevolution Foundation

Customer profile

Segments3 records

Ideal customer profiles3 records

Hevolution Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hevolution Foundation partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • XPRIZE FoundationcoreStrategic or Co-development Partner · 1 January 2021Partnership on the $101 million XPRIZE Healthspan competition to drive breakthroughs in healthy aging. Hevolution co-founded this initiative to accelerate the field of geroscience and incentivize global innovation in healthspan extension.
  • Impetus GrantsminorStrategic or Co-development PartnerStrategic partnership with Impetus Grants as part of Hevolution's global partnerships to accelerate impact, build capacity, acquire knowledge, and increase awareness in healthspan science.
  • AFAR (American Federation for Aging Research)coreStrategic or Co-development PartnerCo-development of Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research, providing $375,000 awards over 3 years to junior investigators in Canada and the United States. Also jointly manages the Hevolution Foundation Scientific Conferences Fund.
  • VandriaminorStrategic or Co-development PartnerInvestment in Lausanne-based Swiss biotech company Vandria as part of Hevolution's portfolio of companies advancing healthspan science.
  • Saudi Arabia National Biotechnology StrategycoreStrategic or Co-development PartnerAlignment with Saudi Arabia's National Biotechnology Strategy which aims to contribute over $34 billion to non-oil GDP by 2040, positioning the Kingdom as a leader in geroscience research.
  • National Institutes of Health (NIH)minorStrategic or Co-development PartnerHevolution's HF-AGE program funds projects that were deemed meritorious in NIH peer review but not funded by the National Institute on Aging (NIA) in fiscal year 2023.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Hevolution Foundation competitors and assessment

Company assessment

Direct peers

  • SENS Research Foundation: SENS is a nonprofit foundation funding research into the biological drivers of aging and age-related disease. It overlaps directly with Hevolution's mission of advancing geroscience research and serves a similar investigator base.
  • Longevity Science Foundation: A nonprofit that funds research and projects aimed at extending healthy human longevity, including through grants and prizes. It is a direct peer in the healthspan philanthropy category, with comparable grantmaking and ecosystem-building activity.
  • AFAR (American Federation for Aging Research): AFAR is a US-based nonprofit that funds aging biology and geroscience research through grants and investigator awards — the closest functional peer to Hevolution. It is also an active co-development partner on the Hevolution/AFAR New Investigator Awards and the Scientific Conferences Fund.

Broad incumbents

  • Altos Labs: A well-capitalized private biotechnology company focused on cellular rejuvenation programming to treat aging and age-related diseases. Comparable as a deep-pocketed private longevity player, but operating as a commercial entity rather than a grantmaking foundation.
  • Howard Hughes Medical Institute: A large biomedical research philanthropy funding scientists and institutes across the life sciences. Comparable in scale and operating model as a major nonprofit research funder with long investment horizons.
  • Wellcome Leap: A nonprofit program funded by the Wellcome Trust that makes large, milestone-driven grants in human health, including aging-related programs. Comparable as a well-capitalized philanthropic health-research funder with global ambitions.
  • Calico Life Sciences: Alphabet-backed R&D company focused on aging biology and age-related diseases. Not a grantmaker, but a deep-pocketed private player in the same healthspan mission, competing for the same scientific talent and discoveries.
  • National Institute on Aging (NIA / NIH): The largest public funder of aging research in the US, supporting a broad biomedical research portfolio. Hevolution's HF-AGE program specifically funds projects deemed meritorious in NIA peer review but unfunded — making NIA both a complementary and competing capital source.

Others

  • XPRIZE Foundation: A nonprofit that runs large incentive competitions to drive breakthrough innovation. Comparable as a prize-based ecosystem builder, and a direct partner through the $101M XPRIZE Healthspan initiative co-founded by Hevolution.

Emerging players

  • Buck Institute for Research on Aging: An independent nonprofit biomedical research institute dedicated to aging research. It is a partial peer — a research operator and grant recipient in the same field — and a potential partner or grantee for Hevolution programs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Hevolution Foundation social profiles

Digital presence

Hevolution Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hevolution Foundation leadership team

Management profile

Number of profiles

Hevolution Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hevolution Foundation M&A and investment

M&A and investment

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hevolution Foundation

What does Hevolution Foundation do?

Hevolution Foundation is a non-profit organization that provides philanthropic grants and early-stage investments to fund aging biology, geroscience, and healthspan research worldwide. The foundation supports academic researchers, postdoctoral fellows, and early-stage biotech companies developing therapeutics that target the root causes of aging, reinvesting any returns back into the field rather than extracting profits.

Is Hevolution Foundation a public or private company?

Hevolution Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Hevolution Foundation founded?

Hevolution Foundation was founded in 2021. It employs 51 to 100 people.

Where is Hevolution Foundation based?

Hevolution Foundation is headquartered in Riyadh, Saudi Arabia, in the Middle East region.

How does Hevolution Foundation make money?

One revenue line is on record: philanthropic grants and early-stage investments.

Who are Hevolution Foundation's main competitors?

Direct peers on record are SENS Research Foundation, Longevity Science Foundation and AFAR (American Federation for Aging Research). Broad incumbents are Altos Labs, Howard Hughes Medical Institute, Wellcome Leap, Calico Life Sciences and National Institute on Aging (NIA / NIH). XPRIZE Foundation is listed as an others. Buck Institute for Research on Aging is listed as an emerging player.

Does Hevolution Foundation have an API?

No public API is recorded for Hevolution Foundation.

What industry is Hevolution Foundation in?

Hevolution Foundation's product category is Philanthropic Research Funding. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGAKAI, Research & Science Grantmaking Foundations. Its NAICS code is 813211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LifespanLongevity Biotech in 2025: The Expert RoundupFive leading longevity biotech experts—Kristen Fortney of BioAge, Mehmood Khan of Hevolution Foundation, Jamie Justice of XPRIZE Healthspan, Nathan Cheng of Healthspan Capital, and Karl Pfleger of AgingBiotech.info—shared their perspectives on the field's progress in 2025, identifying major themes including big pharma's mainstreaming of longevity biology, a wave of large epigenetic reprogramming funding rounds exceeding billions in valuation, Insilico Medicine's successful AI-driven Phase 2a trial for a TNIK inhibitor, and Stealth Bio's accelerated FDA approval for elamipretide. Experts noted that clinical translation remains the primary bottleneck despite scientific advances, citing the need for validated biomarkers and stronger regulatory frameworks, while expressing optimism that 2026 will see multiple clinical milestones from the FGF21 class, senolytic trials, and epigenetic reprogramming programs.AETOSWireHevolution Foundation Appoints William Greene, MD as Chief Investment OfficerHevolution Foundation appointed William Greene, MD, as Chief Investment Officer, overseeing investment strategy and execution. He previously served as CEO of Fountain Therapeutics and Iconic Therapeutics, and spent 12 years at MPM Capital. The foundation plans to expand internationally and pursue impact-focused investments.AETOSWireHevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Recipients AnnouncedHevolution Foundation and AFAR announced 18 three-year grants of $375,000 each, totaling $6.75 million, for early-career investigators in aging biology and geroscience. The awards aim to strengthen the international pipeline of aging researchers and support promising therapeutics.AETOSWireHevolution Foundation Announces Formation of Scientific Advisory Panel of Renowned Experts in Healthspan Science and GeroscienceHevolution Foundation formed a Scientific Advisory Panel of experts in aging and geroscience to guide its healthspan research funding. The panel includes Brian Kennedy, Guido Kroemer, Andrea Maier, Laura Niedernhofer, and Thomas Rando, and serves an advisory role. The foundation plans to open hubs in North America and other global locations.AETOSWireHevolution Foundation Geroscience Research Opportunities (HF-GRO) Awards Unveiled, with a Budget of up to $115M Over Five YearsHevolution Foundation launched HF-GRO, a grants program for pre-clinical aging and geroscience research in the US, Canada, and Europe. The program has a budget of up to $115 million over five years, with project costs of $300,000 to $500,000 annually. Calls for other geographic areas are expected in coming months.AETOSWireHevolution Foundation Advancing Geroscience Efforts (HF-AGE) Grant Recipients AnnouncedHevolution Foundation announced nine grant recipients for its HF-AGE program, which funds NIH-reviewed geroscience research. The program awarded over $3.4 million in 2023, with a projected total of over $20 million through 2027.AETOSWireHevolution Foundation to Host Panel on Healthspan Investing at 2023 BIO International ConventionHevolution Foundation will host a panel on healthspan investing at the BIO International Convention in Boston, June 5-8, 2023. The session, moderated by CIO William Greene, will feature experts from biopharmaceutical and investment fields to discuss opportunities and challenges in the sector.Longevity.Technology‘We need intermediary biomarkers we can trust’Hevolution Foundation released the second edition of its Global Healthspan Report, a comprehensive assessment of the science, technology, investments and policies shaping longevity. Professor David Allison, Chief of Nutrition at Baylor College of Medicine, discusses in an interview the gap between promising findings in animal studies and the lack of clear human evidence for healthspan-boosting interventions, arguing that the field needs trusted intermediary biomarkers to accelerate research translation.Longevity.TechnologyAeovian lands $55m to advance pipeline focused on mTOR biologyUS biotech Aeovian Pharmaceuticals has secured a $55 million Series B funding round, led by Luma Group with participation from longevity-focused investors including Hevolution and Apollo Health Ventures, to advance its lead candidate AV078 into a Phase 2 proof-of-concept study. AV078 is a selective mTORC1 inhibitor designed to treat tuberous sclerosis complex-related refractory epilepsy while potentially avoiding the tolerability issues associated with non-selective mTOR inhibitors. The company views TSC epilepsy as a measurable biological context to validate selective mTORC1 modulation, with the long-term goal of applying this approach to broader age-related conditions characterized by chronic mTORC1 hyperactivation.Fii-InstituteFII Institute’s THINK Pillar Releases Landmark Whitepaper on Healthy Aging with Hevolution FoundationThe FII Institute and the Hevolution Foundation have released a whitepaper titled "Ensuring Global Access to Healthy Aging Solutions: A Strategic Approach," which advocates for extending healthspan through public-private partnerships. The report highlights that adding one year of healthspan could save trillions annually in healthcare costs, yet global investment in longevity research remains insufficient. This release precedes the FII9 conference in Riyadh, aiming to mobilize investors and policymakers to address the aging population crisis.